Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Firebrick Pharma Limited ( (AU:FRE) ).
Firebrick Pharma Limited has announced its Annual General Meeting (AGM) will be held virtually on November 26, 2025, allowing shareholders to participate online. The company has set October 8, 2025, as the deadline for director nominations, which must be submitted in writing to their registered office. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and governance.
More about Firebrick Pharma Limited
Firebrick Pharma is a pharmaceutical innovator specializing in the development and commercialization of novel formulations and uses of povidone-iodine (PVP-I). The company has launched its Nasodine Nasal Spray in the United States, Singapore, and Fiji & South Pacific, with plans to enter the Philippine market in 2026.
Average Trading Volume: 84,129
Technical Sentiment Signal: Sell
Learn more about FRE stock on TipRanks’ Stock Analysis page.